Matches in SemOpenAlex for { <https://semopenalex.org/work/W2117617079> ?p ?o ?g. }
- W2117617079 endingPage "476" @default.
- W2117617079 startingPage "471" @default.
- W2117617079 abstract "Background: Considerable lives and money could be saved if one could detect early stages of lapsing/relapsing behavior in addicted persons (e.g., in safety-sensitive workplaces) and could disclose harmful drinking in social drinkers. Due to the serious public health problem of alcohol use and abuse worldwide, markers of alcohol use have been sought. Both ethyl glucuronide (EtG) and phosphatidyl ethanol (PEth) appear to have high sensitivity and specificity and a time frame of detection that may elucidate alcohol use not detected by standard testing. Our aim was to assess their potential for detecting recent covert alcohol use under controlled conditions. Methods: Thirty-five forensic psychiatric inpatients in a closed ward who had committed a substance-related offense (§64 StGB), were followed for 12 months. The complete time spectrum of possible alcohol consumption was covered by the complementary use of breath and urinary ethanol (hours), urinary EtG (days), %carbohydrate-deficient transferrin (CDT)/PEth (weeks), and γ-glutamyltranspeptidase (GGT)/mean corpuscular volume (MCV) (weeks-months). Results: Fourteen of the 146 urine samples examined were positive for EtG. In all EtG-positive cases, patients reported alcohol consumption of between 40 and 200 g of ethanol 12–60 hr prior to testing. Urinary and breath ethanol were positive in only one case. In the blood samples, PEth was not positive in any case and %CDT did not exceed the reference value. Isoelectric focusing showed no abnormal Tf subtypes. Conclusions: The findings emphasize the diagnostic and therapeutic usefulness, specificity, and sensitivity of EtG as a marker of recent alcohol use. Such a test is needed in numerous settings, including alcohol and drug treatment (to detect lapse/relapse), in safety-sensitive work settings where use is dangerous or in other settings where use may be inappropriate (e.g., such as driving, workplace, pregnancy, or monitoring physicians or other professionals who are in recovery and working), or for testing other groups (such as children or those with medical problems) where alcohol use would be unhealthy or unsafe. The health, social and socioeconomic benefits arising from the future use of these markers is hard to overestimate." @default.
- W2117617079 created "2016-06-24" @default.
- W2117617079 creator A5020548314 @default.
- W2117617079 creator A5023989054 @default.
- W2117617079 creator A5025148339 @default.
- W2117617079 creator A5028485703 @default.
- W2117617079 creator A5039835468 @default.
- W2117617079 creator A5056954575 @default.
- W2117617079 creator A5064918123 @default.
- W2117617079 date "2003-03-01" @default.
- W2117617079 modified "2023-10-12" @default.
- W2117617079 title "Ethyl Glucuronide Discloses Recent Covert Alcohol Use Not Detected by Standard Testing in Forensic Psychiatric Inpatients" @default.
- W2117617079 cites W150095017 @default.
- W2117617079 cites W1565140338 @default.
- W2117617079 cites W1566143091 @default.
- W2117617079 cites W1975944404 @default.
- W2117617079 cites W1992472334 @default.
- W2117617079 cites W2001167531 @default.
- W2117617079 cites W200371110 @default.
- W2117617079 cites W2008738779 @default.
- W2117617079 cites W2017226032 @default.
- W2117617079 cites W2018653716 @default.
- W2117617079 cites W2032901572 @default.
- W2117617079 cites W2048265640 @default.
- W2117617079 cites W2061011779 @default.
- W2117617079 cites W2063452022 @default.
- W2117617079 cites W206558834 @default.
- W2117617079 cites W2074271186 @default.
- W2117617079 cites W2094811044 @default.
- W2117617079 cites W2100302815 @default.
- W2117617079 cites W2103182989 @default.
- W2117617079 cites W2117251309 @default.
- W2117617079 cites W2127005324 @default.
- W2117617079 cites W2152521427 @default.
- W2117617079 cites W2162278070 @default.
- W2117617079 cites W2169794763 @default.
- W2117617079 cites W2170509679 @default.
- W2117617079 cites W4237703632 @default.
- W2117617079 cites W4239822494 @default.
- W2117617079 doi "https://doi.org/10.1097/01.alc.0000057942.57330.e2" @default.
- W2117617079 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12658113" @default.
- W2117617079 hasPublicationYear "2003" @default.
- W2117617079 type Work @default.
- W2117617079 sameAs 2117617079 @default.
- W2117617079 citedByCount "85" @default.
- W2117617079 countsByYear W21176170792012 @default.
- W2117617079 countsByYear W21176170792013 @default.
- W2117617079 countsByYear W21176170792014 @default.
- W2117617079 countsByYear W21176170792015 @default.
- W2117617079 countsByYear W21176170792016 @default.
- W2117617079 countsByYear W21176170792017 @default.
- W2117617079 countsByYear W21176170792018 @default.
- W2117617079 countsByYear W21176170792020 @default.
- W2117617079 countsByYear W21176170792021 @default.
- W2117617079 countsByYear W21176170792022 @default.
- W2117617079 crossrefType "journal-article" @default.
- W2117617079 hasAuthorship W2117617079A5020548314 @default.
- W2117617079 hasAuthorship W2117617079A5023989054 @default.
- W2117617079 hasAuthorship W2117617079A5025148339 @default.
- W2117617079 hasAuthorship W2117617079A5028485703 @default.
- W2117617079 hasAuthorship W2117617079A5039835468 @default.
- W2117617079 hasAuthorship W2117617079A5056954575 @default.
- W2117617079 hasAuthorship W2117617079A5064918123 @default.
- W2117617079 hasConcept C118552586 @default.
- W2117617079 hasConcept C126322002 @default.
- W2117617079 hasConcept C178790620 @default.
- W2117617079 hasConcept C185592680 @default.
- W2117617079 hasConcept C2776330855 @default.
- W2117617079 hasConcept C2778248655 @default.
- W2117617079 hasConcept C2778918659 @default.
- W2117617079 hasConcept C2780026642 @default.
- W2117617079 hasConcept C2780161600 @default.
- W2117617079 hasConcept C2780202252 @default.
- W2117617079 hasConcept C2780740339 @default.
- W2117617079 hasConcept C2780931562 @default.
- W2117617079 hasConcept C2781066024 @default.
- W2117617079 hasConcept C3019635848 @default.
- W2117617079 hasConcept C41625074 @default.
- W2117617079 hasConcept C55493867 @default.
- W2117617079 hasConcept C71924100 @default.
- W2117617079 hasConcept C77411442 @default.
- W2117617079 hasConceptScore W2117617079C118552586 @default.
- W2117617079 hasConceptScore W2117617079C126322002 @default.
- W2117617079 hasConceptScore W2117617079C178790620 @default.
- W2117617079 hasConceptScore W2117617079C185592680 @default.
- W2117617079 hasConceptScore W2117617079C2776330855 @default.
- W2117617079 hasConceptScore W2117617079C2778248655 @default.
- W2117617079 hasConceptScore W2117617079C2778918659 @default.
- W2117617079 hasConceptScore W2117617079C2780026642 @default.
- W2117617079 hasConceptScore W2117617079C2780161600 @default.
- W2117617079 hasConceptScore W2117617079C2780202252 @default.
- W2117617079 hasConceptScore W2117617079C2780740339 @default.
- W2117617079 hasConceptScore W2117617079C2780931562 @default.
- W2117617079 hasConceptScore W2117617079C2781066024 @default.
- W2117617079 hasConceptScore W2117617079C3019635848 @default.
- W2117617079 hasConceptScore W2117617079C41625074 @default.
- W2117617079 hasConceptScore W2117617079C55493867 @default.
- W2117617079 hasConceptScore W2117617079C71924100 @default.